Givaudan Reports Sales in Line With Expectations, Backs Guidance
By Aimee Look
Givaudan reported nine-month sales that aligned with analysts' expectations, and reaffirmed it is likely to exceed its midterm sales growth targets.
The Swiss flavor-and-fragrance company had sales of 5.74 billion Swiss francs ($7.14 billion) for the first nine months of 2025, up 5.7% from the same period the year prior on a like-for-like basis, it said Tuesday.
Analysts had anticipated an average of 5.745 billion francs for sales in the period, according to consensus compiled by the company.
Sales on a like-for-like basis in the company's fragrance and beauty arm increased 8% to 2.92 billion francs, and 3.4% to 2.82 billion francs for its taste and wellbeing division.
Givaudan reiterated that it is likely to exceed the upper end of 4% to 5% like-for-like sales growth on a five-year average for the 2021-25 period.
Write to Aimee Look at aimee.look@wsj.com
(END) Dow Jones Newswires
October 14, 2025 01:31 ET (05:31 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States